Nutri-pharma USA Company Limited Pharmaceutical Import Profile — Vietnam (DGFT 2022–2026)

Name: Nutri-pharma USA Company Limited Pharmaceutical Import Records from India — 2 Products, $983.1K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Nutri-pharma USA Company Limited — Pharmaceutical Importer Profile (2026) | 2 Products, $983.1K Trade | TransData Nexus

Nutri-pharma USA Company Limited

Pharmaceutical Importer · Vietnam · Gastrointestinal Focus · $983.1K Total Trade · DGFT Verified

Nutri-pharma USA Company Limited is a pharmaceutical importer based in Vietnam with a total trade value of $983.1K across 2 products in 2 therapeutic categories. Based on 21 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Nutri-pharma USA Company Limited sources from 8 verified Indian suppliers, with Micro Labs Limited accounting for 76.8% of imports.

Nutri-pharma USA Company Limited — Import Portfolio & Supplier Network

Nutri-pharma USA Company Limited import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Nutri-pharma USA Company Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Micro Labs Limited	$2.7M	91	76.8%
Srs Pharmaceuticals Private Limited	$260.8K	8	7.4%
Zeiss Pharmaceuticals Private Limited	$187.5K	13

What Formulations Does Nutri-pharma USA Company Limited Import?

Formulation	Value	Ships
Omicap-20 (omeprazole capsules 20MG)	$193.0K	4
Omicap-20 (omeprazole 20MG capsules)	$156.1K	4
Atendex 2 ML (lincomycin hydrochioride	$150.0K	3
Lecefti - 200 (cefixime 200MG) Box of	$100.0K	2
Cifataze dt 100 (cefixime dispersible tablets 100MG) (1x10s) - tax invoice no: 707202124 dt	$97.3K	3
Santax 1.0 g cefotaxim for injection	$94.1K	6
Newtop 200 (cefixime trihydrate 200MG) batch no:309401 & 309402 mfg.date: 10.04.2024 exp. date: 09.04.2027	$88.0K	3
Cifataze dt 200 (cefixime dispersible tablets 200MG) (1x10s) - tax invoice no: 707202124 dt	$82.0K	3
Neurocetam - 800 ( (piracetam tablets	$79.4K	2
New top sachet (cefixime trihydrate 100MG) batch no.: 262403, 262404 mfg. date 20.04.2024 exp. date	$78.9K	3
Neurocetam-400 ( (piracetam capsules	$56.1K	2
Alcoclear(metadoxine tablets 500MG	$50.0K	1
Macoxy 200 ( (cefpodoxime proxetil	$50.0K	1
Alcoclear ( (metadoxine 500MG tablets) )	$50.0K	1
Newtop 200 cefixime trihydrate 200MG	$50.0K	1

Nutri-pharma USA Company Limited imports 87 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Omeprazole	Gastrointestinal	$900.0K	18	0.1%	14
2	Roxithromycin	Advanced Antibiotics	$83.1K	3	2.0%	11

Nutri-pharma USA Company Limited imports 2 pharmaceutical products across 2 categories into Vietnam totaling $983.1K.

Nutri-pharma USA Company Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Nutri-Pharma USA Company Limited, established on October 9, 2012, is a Vietnamese pharmaceutical importer headquartered in Ho Chi Minh City. The company specializes in the wholesale distribution of pharmaceutical products, focusing on finished formulations such as tablets, capsules, syrups, and injections. Its primary business activity is the wholesale of other household products, including pharmaceutical goods. (companieshouse.vn)

The company's registered address is 710-712 Cách Mạng Tháng Tám, Phường 5, Quận Tân Bình, Ho Chi Minh City, Vietnam. The legal representative is Đinh Thị Hoàng Oanh. (companieshouse.vn) Nutri-Pharma USA Company Limited plays a significant role in Vietnam's pharmaceutical distribution network by importing and supplying a range of pharmaceutical products to meet the country's healthcare needs.

2Distribution Network

While specific details about Nutri-Pharma USA Company Limited's warehouse locations and logistics capabilities are not publicly disclosed, the company's import activities suggest a well-established distribution network. The company has imported a total of $983,000 worth of pharmaceutical products from India across 21 shipments, indicating a consistent and reliable supply chain.

The geographic coverage of Nutri-Pharma USA Company Limited's distribution network is primarily within Vietnam, serving various regions to meet the pharmaceutical demands of the population. The company's strategic location in Ho Chi Minh City, a major commercial hub, facilitates efficient logistics and distribution operations.

3Industry Role

Nutri-Pharma USA Company Limited operates as a pharmaceutical importer and wholesaler within Vietnam's pharmaceutical supply chain. The company imports finished pharmaceutical formulations from India, including products like Omeprazole and Roxithromycin, and distributes them to various stakeholders in the Vietnamese healthcare sector.

By focusing on the import and wholesale distribution of pharmaceutical products, Nutri-Pharma USA Company Limited plays a crucial role in ensuring the availability of essential medications in Vietnam, thereby contributing to the country's healthcare infrastructure.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Nutri-pharma USA Company Limited

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Nutri-Pharma USA Company Limited's sourcing strategy exhibits a high degree of concentration, with the top five products accounting for 100% of its imports. The primary products imported are Omeprazole ($900,000) and Roxithromycin ($83,000), which together constitute the entire import portfolio.

This sourcing concentration indicates a strategic focus on specific therapeutic areas, particularly gastrointestinal and advanced antibiotics. While this approach allows for specialization and potential cost efficiencies, it also exposes the company to risks associated with dependency on a limited product range. Any disruptions in the supply chain for these key products could significantly impact the company's operations.

The shipment data reveals a stable relationship with Indian suppliers, with Micro Labs Limited accounting for 76.8% of the shipments. This suggests a strong and reliable partnership, which is beneficial for maintaining consistent product quality and supply. However, the lack of diversification in the product portfolio may limit the company's ability to adapt to changing market demands or regulatory shifts.

2Supply Chain Resilience

Nutri-Pharma USA Company Limited's supply chain resilience is closely tied to its sourcing strategy. The company's reliance on a limited number of products and suppliers, particularly Micro Labs Limited, indicates a focused but potentially vulnerable supply chain. While the strong relationship with this supplier may ensure consistent product quality and availability, the lack of diversification could pose challenges in the event of supply disruptions.

Importing Pharmaceuticals into Vietnam — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Vietnam

1Regulatory Authority & Framework

In Vietnam, the primary regulatory authority overseeing pharmaceutical imports is the Drug Administration of Vietnam (DAV), operating under the Ministry of Health. The DAV is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products entering the Vietnamese market. (hmlf.vn)

Key legislation governing pharmaceutical imports includes the Law on Pharmacy No. 105/2016/QH13, issued on April 6, 2016, and Decree No. 54/2017/ND-CP, issued on May 8, 2017. These regulations outline the conditions and procedures for importing pharmaceutical products, including requirements for import licenses, product registration, and market authorization. (hmlf.vn)

2Import Licensing & GMP

To import pharmaceutical products into Vietnam, companies must obtain an import license issued by the Ministry of Health. This license is granted to entities that meet specific conditions, including compliance with Good Manufacturing Practice (GMP) standards. The GMP certification must be recognized by the DAV, ensuring that imported products meet the required quality standards. (hmlf.vn)

Additionally, companies must possess wholesale distribution authorization to legally distribute pharmaceutical products within Vietnam. This authorization ensures that distributors adhere to regulatory requirements and maintain the integrity of the pharmaceutical supply chain. (hmlf.vn)

Nutri-pharma USA Company Limited — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Nutri-Pharma USA Company Limited's product strategy focuses on importing and distributing pharmaceutical products in the gastrointestinal and advanced antibiotics therapeutic categories. The company's top two imported products, Omeprazole and Roxithromycin, align with these therapeutic areas, indicating a strategic emphasis on addressing specific medical needs within the Vietnamese market.

The market demand for these products is driven by the prevalence of gastrointestinal disorders and bacterial infections in Vietnam. By focusing on these therapeutic areas, Nutri-Pharma USA Company Limited aims to provide essential medications that are in high demand, thereby contributing to the overall healthcare infrastructure of the country.

2Sourcing Profile

Nutri-Pharma USA Company Limited's sourcing strategy is centered on importing finished pharmaceutical formulations from India, with a particular focus on products like Omeprazole and Roxithromycin. The company's reliance on a single supplier, Micro Labs Limited, for a significant portion of its imports suggests a strategic choice to maintain consistent product quality and supply.

This approach allows the company to leverage established relationships and potentially negotiate favorable terms. However, the lack of diversification in the supplier base may expose the company to risks associated with supply chain disruptions or changes in supplier dynamics.

Frequently Asked Questions — Nutri-pharma USA Company Limited

What products does Nutri-pharma USA Company Limited import from India?

Nutri-pharma USA Company Limited imports 2 pharmaceutical products across 2 categories. Top imports: Omeprazole ($900.0K), Roxithromycin ($83.1K).

Who supplies pharmaceuticals to Nutri-pharma USA Company Limited from India?

Nutri-pharma USA Company Limited sources from 8 verified Indian suppliers. The primary supplier is Micro Labs Limited (76.8% of imports, $2.7M).

What is Nutri-pharma USA Company Limited's total pharmaceutical import value?

Nutri-pharma USA Company Limited's total pharmaceutical import value from India is $983.1K, based on 21 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Nutri-pharma USA Company Limited focus on?

Nutri-pharma USA Company Limited imports across 2 categories. The largest: Gastrointestinal (91.5%), Advanced Antibiotics (8.5%).

Get Full Nutri-pharma USA Company Limited Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Nutri-pharma USA Company Limited

Nutri-pharma USA Company Limited — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Nutri-pharma USA Company Limited?

What Formulations Does Nutri-pharma USA Company Limited Import?

What Products Does Nutri-pharma USA Company Limited Import?

Top Products by Import Value

Nutri-pharma USA Company Limited Therapeutic Categories — 2 Specializations